Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma.
Molecular Cancer Therapeutics
Shigeta, Shogo S; Lui, Goldie Y L GYL; Shaw, Reid R; Moser, Russell R; Gurley, Kay E KE; Durenberger, Grace G; Rosati, Rachele R; Diaz, Robert L RL; Ince, Tan A TA; Swisher, Elizabeth M EM; Grandori, Carla C; Kemp, Christopher J CJ
Publication Date: 2021-04
Variant appearance in text: ARID1A: 347del; N116Tfs*116